Teladoc Health Reports Third Quarter 2026 Results
Teladoc reported Q3 2026 revenue of $605.1 million, down 3% year-over-year, with adjusted EBITDA of $79.4 million up 14% and above its guidance range. Integrated Care grew 2% to $398.5 million with an 18.8% EBITDA margin, while BetterHelp fell 13% to $206.6 million as out-of-pocket users declined 12%. Net loss narrowed 46% to $26.9 million ($0.15 per share), and free cash flow was $75.9 million.
Key figures
- Revenue
- 605100000
- Guidance
- FY26 revenue $2,395-$2,441M; adjusted EBITDA $277-$303M; net loss per share ($0.95)-($0.75); FCF $135-$165M; Q4 revenue $569-$615M, adjusted EBITDA $74-$100M
- Revenue Yoy
- -3%
- Fcf
- 75900000
- Adjusted ebitda
- 79400000
- Betterhelp revenue
- 206600000
- Adjusted ebitda yoy
- +14%
- Betterhelp revenue yoy
- -13%
- Betterhelp paying users
- 336000
- Integrated care revenue
- 398500000
- Betterhelp ebitda margin
- 2.2%
- Betterhelp paying users yoy
- -12%
- Integrated care revenue yoy
- +2%
- Integrated care ebitda margin
- 18.8%
- Us integrated care members millions
- 100.1
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.